Treatment of Pseudotumor Cerebri with Digoxin

Update item information
Identifier 19900204_nanos_sciplatform1_06
Title Treatment of Pseudotumor Cerebri with Digoxin
Creator James A. Goodwin, MD, University of Illinois Hospital
Subject Pseudotumor Cerebri; Digoxin Treatment; Acetazolamide; Transient Visual Obscurations; Idiopathic Intracranial Hypertension
Description Acetazolamide is a carbonic anhydrase inhibitor that reduces cerebrospinal fluid (CSF) production by about 50% (Maren 1972, McCarthy & Reed 1974) and lowers intracranial pressure. Acetazolamide commonly achieves long lasting control of transient visual obscurations (1VO), headache and diplopia, all of which are manifestations of intracranial hypertension, even though papilledema does not completely resolve. The effect of acetazolamide on intracranial pressure has been shown to be unsustained (Plum & Slesjo 1975), and many patients develop side effects sufficiently severe that compliance is hindered.
Relation is Part of NANOS 1990: Scientific Platform Presentations (Session 1)
Contributor Primary Corbett, James J
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 1990-02-04
Type Text
Format application/pdf
Format Creation application/pdf
Source 1990 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6p58v4m
Setname ehsl_novel_nam
Date Created 2013-11-05
Date Modified 2021-05-06
ID 183143
Reference URL
Back to Search Results